about
ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndromeLigand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcriptionSelective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applicationsSelective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safetyAnti-androgen treatments.ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional ConsequencesA new strategy for selective targeting of progesterone receptor with passive antagonists.Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study.Multiple miscarriages are associated with the risk of ovarian cancer: results from the European Prospective Investigation into Cancer and NutritionGnRH antagonists.Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression.Contraceptive applications of progesterone receptor modulators.Effects of antiprogestins on the uterus.Pregnancy after breast cancer: a need for global patient care, starting before adjuvant therapy.The future of women's contraception: stakes and modalities.Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial.The immninent dawn of SPRMs in obstetrics and gynecology.Toward a new concept of "natural balance" in oral estroprogestin contraception.Fibroid growth and medical options for treatment.The history and use of the progesterone receptor modulator ulipristal acetate for heavy menstrual bleeding with uterine fibroids.Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.Use of Bisphosphonates and Risk of Breast Cancer in a French Cohort of Postmenopausal Women.Clinicopathologic Characteristics of Endometrial Cancer in Lynch Syndrome: A French Multicenter Study.Anti-Tumoral Effects of Anti-Progestins in a Patient-Derived Breast Cancer Xenograft Model.Finding the balance between surgery and medically-assisted reproduction in women with deep infiltrating endometriosis.Hormonal prevention of breast cancer.From Pregnancy to Preeclampsia: A Key Role for Estrogens.
P50
Q24310286-2063F4F2-0B77-4126-B00F-C4EC0B9A3211Q28236995-FD212CB5-5802-487E-913C-81313CFA1FC4Q28241710-8455C0D8-C33D-4DF4-BFEC-91181F13D76AQ28248986-41D1A7CD-2A8B-4A23-8548-6FCD3E5BF5B3Q33526116-E603CAC4-521F-48BA-9DC8-F94AC646E618Q33570265-F1EEE3BA-CF6E-4BEC-94F4-3296048B7F66Q33633141-53B77142-82FF-431F-BDEC-248DE17C56ECQ34252237-9F12C93D-4FDD-455C-B5EB-1742C2B4A5A8Q34279823-D7F65CBF-34EA-47BC-97D4-BEEEA29F0801Q35155087-34554F7E-A2EF-4031-BBF8-9D103E1BCD53Q35810608-DBBAAB60-2FBE-45C8-ACA2-BA09EF53D391Q37280942-9FEC6962-FBF1-4D81-8E6A-D0CAAC87B3C6Q37346109-2606BBDF-4C89-4DD4-A4B7-E268E7A31743Q37482807-63B9E5CF-C202-4B79-AD6D-DF02130CC13DQ37788765-2F6A1523-2DAA-4EE5-881C-9ACB256459B4Q37955050-42FF7CE8-D9A3-4D79-8100-023270084933Q37993384-6A957D2F-0A32-403E-BFB1-E613FD707DC1Q38127769-EF62D308-9746-4808-8BA8-84936F500651Q38244678-F57BC572-B50D-4880-B154-7578CB4B5EB8Q38289151-9F393D79-9772-498F-9BC2-C7501E983FD2Q38501601-4B4E6457-B680-4160-B92B-C3FCF50B2FB1Q38679080-0CED89A3-4AAF-422B-9B6E-434E24E453AFQ38774201-E1D3437E-D300-494A-A0E1-85C47BAF23D0Q38789039-A056D0FC-DC0B-4185-B6C4-DF73B81F9840Q38813211-0E888D79-B9BC-4673-A707-7E4BDF7025EEQ39164143-45736C5F-D5E4-4F2E-B226-DF7E583D3004Q39190447-24F4F899-2D3C-4C22-A203-67111FBD519B
P50
description
onderzoeker
@nl
name
Nathalie Chabbert-Buffet
@ast
Nathalie Chabbert-Buffet
@en
Nathalie Chabbert-Buffet
@es
Nathalie Chabbert-Buffet
@sl
type
label
Nathalie Chabbert-Buffet
@ast
Nathalie Chabbert-Buffet
@en
Nathalie Chabbert-Buffet
@es
Nathalie Chabbert-Buffet
@sl
prefLabel
Nathalie Chabbert-Buffet
@ast
Nathalie Chabbert-Buffet
@en
Nathalie Chabbert-Buffet
@es
Nathalie Chabbert-Buffet
@sl
P214
P106
P21
P213
0000 0003 5915 5392
P214
P31
P735
P7859
viaf-215053041